-->
Home > E. Pathology by systems > Endocrine system > Thyroid > thyroid papillary carcinoma

| PubMed | eMedicine | OMIM | Google | Google images | Yahoo images | YouTube |

  • Printer friendly version

thyroid papillary carcinoma

Thyroid papillary carcinoma. Macroscopy. Thyroid papillary carcinoma Thyroid papillary carcinoma Thyroid papillary carcinoma Thyroid papillary carcinoma Thyroid papillary carcinoma Thyroid papillary carcinoma (tumoral extension in thyroid parenchyma) Thyroid papillary carcinoma Thyroid papillary carcinoma Thyroid papillary carcinoma (after formalin fixation) Thyroid papillary carcinoma Thyroid papillary carcinoma Thyroid papillary carcinoma Thyroid papillary carcinoma Thyroid papillary carcinoma Thyroid papillary carcinoma Thyroid papillary carcinoma Thyroid papillary carcinoma Thyroid papillary carcinoma Thyroid papillary carcinoma Thyroid papillary carcinoma Thyroid papillary carcinoma Thyroid papillary carcinoma Thyroid papillary carcinoma Thyroid papillary carcinoma Thyroid papillary carcinoma Thyroid papillary carcinoma Thyroid papillary carcinoma Thyroid papillary carcinoma Thyroid papillary carcinoma Thyroid papillary carcinoma Thyroid papillary carcinoma

Clinical synops

- 5-20% have local recurrences
- 10-15% distant metastases (lung, bones, CNS)is
- women of reproductive age (70%)
- 90% of childhood thyroid malignancies are papillary
- 6% Occult tumorsat autopsy (1 to 10 mm)
- 46% multicentric
- 14% with nodal metastases
- Occult tumors in up to 24% with other thyroid disease, surprisingly with male predominance
- painless nodule
- mass in neck or cervical node

  • 67% in thyroid only, 13% in thyroid and cervical nodes, 20% in nodes only

Risk factors

- ionizing radiation before age 20 (for acne, tonsillitis, tinea capitis)
- post-Chernobyl or nuclear explosions at Marshall Islands
- Hashimoto thyroiditis
- Gardner syndrome with germline APC mutations
- multiple hamartomas syndrome (Cowden syndrome)

Prognosis

- 10 year survival:

  • 98%, similar to general population
  • 100% if under age 20, even with nodal metastases

- Cervical node involvement does not affect the prognosis.
- Poorer prognosis:

  • age 40+ or elderly
  • male
  • local invasion
  • distant metastases (bone worse than lung)
  • large tumor size
  • tall cell/columnar variant
  • diffuse sclerosing variant
  • exposure to radiation
  • lymphatic invasion

Synopsis

- Gross: solid, white, firm, often multifocal (20%), encapsulated (10%) or infiltrative; variable cysts, fibrosis, calcification
- complex, branching papillae with fibrovascular cores associated with follicles
- nuclei are overlapping with finely dispersed optically clear chromatin (also called ground-glass, Orphan-Annie nuclei, not seen in cytology or frozen section material)
- micronucleoli
- eosinophilic intranuclear inclusions (cytoplasmic invaginations)
- nuclear longitudinal grooves (folding of redundant nuclear membrane)
- psammoma bodies

  • present in 50% in papillary stalk in fibrous stroma between tumor cells;
  • +/- specific for papillary carcinoma

- +/- vascular invasion (5%)
- +/- dense fibrosis
- +/- squamous metaplasia
- +/- solid areas
- +/- inflammatory cells: lymphocytes, histiocytes, histiocytic multinucleate giant cells, Langerhans cells
- +/- spindle cell metaplasia
- +/- mitotic figures
- +/- mucinous metaplasia

Differential diagnosis

- lymphocytic thyroiditis with reactive nuclear changes

  • nuclei are still round, no inclusions
  • background of lymphocytes and plasma cells without fibrosis

- hyperplastic ultimobranchial body rests / solid cell nests

  • in lateral lobes
  • round to oval structures
  • +/- chromatin clearing or grooves
  • central cysts
  • mucin
  • squamous metaplasia
  • cytokeratin strongly positive, thyroglobulin negative

- papillary foci of Graves’disease

  • strong p27 staining vs. weak in papillary carcinoma

- tumoral metastases

Variants

- columnar TPC
- cribriform-morular TPC
- diffuse sclerosing TPC
- follicular TPC
- encapsulated TPC
- encapsulated follicular TPC
- Hashimoto thyroiditis TPC
- macrofollicular TPC
- microcarcinoma TPC
- nodular fasciitis like stroma TPC
- oncocytic TPC
- solid TPC
- tall cell TPC
- Warthin-like TPC
- well differentiated TPC

Predisposition

- familial papillary thyroid carcinoma (FPTC)
- familial adenomatous polyposis (FAP) (16400511, 15256777, 7698732)

Chromosomal comparative genomic hybridization (CGH)

- low prevalence of aberrations
- majority of tumors showing no evidence of chromosomal instability

- gains: chromosomes 1, 5, 7, 11, 15, 17, and 22

- losses: chromosomes 4, 18, and 19

Regional amplification

- TP73 (1p36 amplification)
- SNRPN (15q12 amplification)
- PDGFB (22q13 amplification)

Gene mutations

Oncogenic activation of BRAF (35% to 69%), RAS (10%), or RET (5% to 30%) is common in PTC, and the mutations correlate with tumor subtype, patient age, and clinical behavior.

- BRAF mutations (35% to 69%) (17199440)
- RAS mutations (10%)
- RET mutations (5% to 30%)

See also

- ovarian papillary thyroid carcinoma (malignant struma ovarii).

References

- Finn S, Smyth P, O’Regan E, Cahill S, Toner M, Timon C, Flavin R, O’Leary J, Sheils O. Low-level genomic instability is a feature of papillary thyroid carcinoma: an array comparative genomic hybridization study of laser capture microdissected papillary thyroid carcinoma tumors and clonal cell lines. Arch Pathol Lab Med. 2007 Jan;131(1):65-73. PMID: 17227125

- McCarthy RP, Wang M, Jones TD, Strate RW, Cheng L. Molecular evidence for the same clonal origin of multifocal papillary thyroid carcinomas. Clin Cancer Res. 2006 Apr 15;12(8):2414-8. PMID: 16638846